Article: NRP104: WILL A NEW ADHD TREATMENT MAKE OR BREAK NEW RIVER PHARMACEUTICALS? [Corrected 02/14/07]

A green light glowed Friday for a clutch of Radford drug executives who received tentative approval to sell a potentially lucrative treatment for attention deficit hyperactivity disorder.

New River Pharmaceuticals Inc. said the approval "is contingent upon final scheduling by the U.S. Drug Enforcement Administration."

The company predicted sales will begin during the April-June quarter of 2007. New River previously hired Organichem Corp. of Rensselaer, N.Y., to produce the pills. Officials don't envision filling any new manufacturing jobs.

But the Food and Drug Administration gave Western Virginia a regional business milestone: a homegrown biotechnology company taking

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!